Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

NewsGuard 100/100 Score
Jun 25 2015

Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market® ("NASDAQ") on June 29, 2015 under the symbol CXRX.

The Company's common shares will continue to trade on the Toronto Stock Exchange.

"Our NASDAQ listing will provide increased exposure for Concordia as we continue to build our foundation as an emerging leader in the acquisition of legacy pharmaceutical products and orphan drugs," said Mark Thompson, Chief Executive Officer of Concordia.

SOURCE Concordia Healthcare Corp.

Posted in: Business / Finance

Tags: , , , , , , , , , , , ,

Comments (0)

Suggested Reading

Study shines light on the well-being challenges faced by women in healthcare
UK Government donates £2 million worth of medical equipment to Ukraine
Millimeter-scale magnetic implants for wireless health monitoring
Emerging trends in wearable breath sensors aim at personalized healthcare solutions
Top minds in multiple sclerosis to speak at CMSC 38th Annual Meeting
Empowering Change: How Hologic is Shaping the Future of Women's Healthcare
New study aims to reduce bias in AI health prediction models
Can generative AI truly transform healthcare into a more personalized experience?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
WHO issues ethical guidelines for AI in healthcare, focusing on large multi-modal models